These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 30805547)

  • 1. Electrocardiographic disturbances in children with systemic lupus erythematosus.
    AlTwajery M; AlMane W; Al-Mayouf SM
    Int J Pediatr Adolesc Med; 2018 Dec; 5(4):127-130. PubMed ID: 30805547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. QT interval parameters, anti-Ro antibody status, and disease activity in systemic lupus erythematosus.
    Azharudeen M; Thabah MM; Satheesh S; Negi VS
    J R Coll Physicians Edinb; 2020 Dec; 50(4):380-386. PubMed ID: 33469612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obstetric and perinatal outcome in anti-Ro/SSA-positive pregnant women: a prospective cohort study.
    Martínez-Sánchez N; Pérez-Pinto S; Robles-Marhuenda Á; Arnalich-Fernández F; Martín Cameán M; Hueso Zalvide E; Bartha JL
    Immunol Res; 2017 Apr; 65(2):487-494. PubMed ID: 28138914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrocardiographic findings in systemic lupus erythematosus: data from an international inception cohort.
    Bourré-Tessier J; Urowitz MB; Clarke AE; Bernatsky S; Krantz MJ; Huynh T; Joseph L; Belisle P; Bae SC; Hanly JG; Wallace DJ; Gordon C; Isenberg D; Rahman A; Gladman DD; Fortin PR; Merrill JT; Romero-Diaz J; Sanchez-Guerrero J; Fessler B; Alarcón GS; Steinsson K; Bruce IN; Ginzler E; Dooley MA; Nived O; Sturfelt G; Kalunian K; Ramos-Casals M; Petri M; Zoma A; Pineau CA
    Arthritis Care Res (Hoboken); 2015 Jan; 67(1):128-35. PubMed ID: 24838943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged corrected QT interval in anti-Ro/SSA-positive adults with systemic lupus erythematosus.
    Bourré-Tessier J; Clarke AE; Huynh T; Bernatsky S; Joseph L; Belisle P; Pineau CA
    Arthritis Care Res (Hoboken); 2011 Jul; 63(7):1031-7. PubMed ID: 21452253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-RO/SSA and anti-La/SSB antibodies: Association with mild lupus manifestations in 645 childhood-onset systemic lupus erythematosus.
    Novak GV; Marques M; Balbi V; Gormezano NW; Kozu K; Sakamoto AP; Pereira RM; Terreri MT; Magalhães CS; Guariento A; Sallum AM; Marini R; Ferriani VP; Barbosa CM; de Castro TC; Ramos VC; Bonfá E; Silva CA
    Autoimmun Rev; 2017 Feb; 16(2):132-135. PubMed ID: 27988434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hematological involvement in pediatric systemic lupus erythematosus: A multi-center study.
    Akca ÜK; Batu ED; Kısaarslan AP; Poyrazoğlu H; Ayaz NA; Sözeri B; Sağ E; Atalay E; Demir S; Karadağ ŞG; Demir F; Bilginer Y; Gümrük F; Özen S
    Lupus; 2021 Oct; 30(12):1983-1990. PubMed ID: 34459313
    [No Abstract]   [Full Text] [Related]  

  • 8. Pregnancy outcome of 126 anti-SSA/Ro-positive patients during the past 24 years--a retrospective cohort study.
    Luo Y; Zhang L; Fei Y; Li Y; Hao D; Liu Y; Zhao Y
    Clin Rheumatol; 2015 Oct; 34(10):1721-8. PubMed ID: 26384980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the risk of anti-SSA/Ro-SSB/La antibody-associated cardiac manifestations of neonatal lupus in fetuses of mothers with systemic lupus erythematosus exposed to hydroxychloroquine.
    Izmirly PM; Kim MY; Llanos C; Le PU; Guerra MM; Askanase AD; Salmon JE; Buyon JP
    Ann Rheum Dis; 2010 Oct; 69(10):1827-30. PubMed ID: 20447951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to extractable nuclear antigens (ENAS) in systemic lupus erythematosus patients: correlations with clinical manifestations and disease activity.
    Emad Y; Gheita T; Darweesh H; Klooster P; Gamal R; Fathi H; El-Shaarawy N; Gamil M; Hawass M; El-Refai RM; Al-Hanafi H; Abd-Ellatif S; Ismail A; Rasker J
    Reumatismo; 2018 Jul; 70(2):85-91. PubMed ID: 29976042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of cardiac screening in patients with systemic lupus erythematosus and anti-Ro/SSA antibodies.
    Villuendas R; Martínez-Morillo M; Juncà G; Teniente-Serra A; Diez C; Heredia S; Riveros-Frutos A; Bayés-Genís A; Olivé A
    Lupus; 2021 Sep; 30(10):1596-1602. PubMed ID: 34192953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and Associated Factors of Electrocardiogram Abnormalities in Patients With Systemic Lupus Erythematosus: A Machine Learning Study.
    Hu Z; Wu L; Lin Z; Liu X; Zhao C; Wu Z
    Arthritis Care Res (Hoboken); 2022 Oct; 74(10):1640-1648. PubMed ID: 33787068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neonatal lupus: Follow-up in infants with anti-SSA/Ro antibodies and review of the literature.
    Zuppa AA; Riccardi R; Frezza S; Gallini F; Luciano RM; Alighieri G; Romagnoli C; De Carolis S
    Autoimmun Rev; 2017 Apr; 16(4):427-432. PubMed ID: 28212920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac Abnormalities in Relation to the Disease Activity Index Among Systemic Lupus Erythematosus Patients in a Tertiary Hospital: A Cross-Sectional Study.
    Attuquayefio S; Doku A; Dey D; Agyekum F; Akumiah FK; Kweki AG; Amaechi UM; Aiwuyo HO
    Cureus; 2023 Nov; 15(11):e49495. PubMed ID: 38152811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypergammaglobulinemic purpura in systemic autoimmune rheumatic diseases: predictive value of anti-Ro(SSA) and anti-La(SSB) antibodies and treatment with indomethacin and hydroxychloroquine.
    Senécal JL; Chartier S; Rothfield N
    J Rheumatol; 1995 May; 22(5):868-75. PubMed ID: 8587074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. QT dispersion in patients with systemic lupus erythematosus: the impact of disease activity.
    Kojuri J; Nazarinia MA; Ghahartars M; Mahmoody Y; Rezaian Gr; Liaghat L
    BMC Cardiovasc Disord; 2012 Feb; 12():11. PubMed ID: 22369270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular mechanism of the conduction abnormalities induced by serum from anti-Ro/SSA-positive patients in rabbit hearts.
    Garcia S; Nascimento JH; Bonfa E; Levy R; Oliveira SF; Tavares AV; de Carvalho AC
    J Clin Invest; 1994 Feb; 93(2):718-24. PubMed ID: 8113406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between anti-SSA autoantibodies and conduction disturbances in heart failure.
    Hua C; Jiang C; Wang Z; Liu X; Fu H; Lin J; Lv Q; Dong J; Ma C; Du X
    Heart Rhythm; 2024 Jun; ():. PubMed ID: 38848863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for cardiac safety and antiarrhythmic potential of chloroquine in systemic lupus erythematosus.
    Teixeira RA; Borba EF; Pedrosa A; Nishioka S; Viana VS; Ramires JA; Kalil-Filho R; Bonfá E; Martinelli Filho M
    Europace; 2014 Jun; 16(6):887-92. PubMed ID: 24050965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cumulative dose of hydroxychloroquine is associated with a decrease of resting heart rate in patients with systemic lupus erythematosus: a pilot study.
    Cairoli E; Danese N; Teliz M; Bruzzone MJ; Ferreira J; Rebella M; Cayota A
    Lupus; 2015 Oct; 24(11):1204-9. PubMed ID: 25852050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.